Division of Clinical and Metabolic Genetics, The Hospital for Sick Children, Toronto, ON, Canada.
Clin Genet. 2013 May;83(5):399-407. doi: 10.1111/cge.12101. Epub 2013 Feb 21.
Autism spectrum disorders (ASDs) are a heterogeneous group of neurodevelopmental disorders affecting social communication, language and behavior. The underlying cause(s) in a given individual is often elusive, with the exception of clinically recognizable genetic syndromes with readily available molecular diagnosis, such as fragile X syndrome. Clinical geneticists approach patients with ASDs by ruling out known genetic and genomic syndromes, leaving more than 80% of families without a definitive diagnosis and an uncertain risk of recurrence. Advances in microarray technology and next-generation sequencing are revealing rare variants in genes with important roles in synapse formation, function and maintenance. This review will focus on the clinical approach to ASDs, given the current state of knowledge about their complex genetic architecture.
自闭症谱系障碍(ASD)是一组影响社交沟通、语言和行为的神经发育障碍,具有异质性。除了脆性 X 综合征等具有现成分子诊断的临床可识别遗传综合征外,特定个体的潜在病因通常难以捉摸。临床遗传学家通过排除已知的遗传和基因组综合征来治疗 ASD 患者,这使得超过 80%的家庭无法做出明确的诊断,并且不确定复发的风险。微阵列技术和下一代测序技术的进步揭示了在突触形成、功能和维持中具有重要作用的基因中的罕见变异。鉴于目前对其复杂遗传结构的了解,本综述将重点介绍 ASD 的临床方法。